Epithelial-mesenchymal transdifferentiation (EMT) is a critical morphogenic event that occurs during embryonic development and during the progression of various epithelial tumors. EMT can be induced by transforming growth factor (TGF)-b in mouse NMuMG mammary epithelial cells. Here, we demonstrate a central role of helix-loop-helix factors, E2A and inhibitor of differentiation (Id) proteins, in TGF-b-induced EMT. Epithelial cells ectopically expressing E2A adopt a fibroblastic phenotype and acquire migratory/invasive properties, concomitant with the suppression of E-cadherin expression. Id proteins interacted with E2A proteins and antagonized E2A-dependent suppression of the E-cadherin promoter. Levels of Id proteins were dramatically decreased by TGF-b. Moreover, NMuMG cells overexpressed Id2 showed partial resistance to TGF-b-induced EMT. Id proteins thus inhibit the action of E2A proteins on the expression of E-cadherin, but after TGF-b stimulation, E2A proteins are present in molar excess of the Id proteins, thus over-riding their inhibitory function and leading to EMT.
Introduction
Transforming growth factor (TGF)-b, a prototypic member of the TGF-b superfamily, exhibits a broad range of biological activities. It has an antiproliferative effect on divergent cell types, including epithelial cells, endothelial cells and hematopoietic cells. Thus, perturbations of TGF-b signaling result in the progression of certain tumors. In contrast to its antiproliferative effects on most cell types, TGF-b also promotes growth of mesenchymal cell types, including fibroblasts, chondrocytes and osteoblasts. Moreover, if cells acquire resistance to the growth inhibitory effects of TGF-b, TGF-b contributes to the progression of tumors through the induction of angiogenesis, extracellular matrix accumulation and immunosuppression. [1] [2] [3] [4] Members of the TGF-b superfamily, including TGF-bs, activins, bone morphogenetic proteins (BMPs) and growth/ differentiation factors, transmit their pleiotropic effects through transmembrane serine/threonine kinase type I and type II receptors. 1, 5 Upon ligand-induced heteromeric complex formation between type I and type II receptors, the type I receptor becomes phosphorylated and activated by the type II receptor kinase, and mediates specific intracellular signals. Smads are the central signal mediators of the TGF-b superfamily activated by type I receptor kinases. Smads are subdivided into three subtypes: receptor-regulated Smads (RSmads), common-mediator Smad (Smad4) and inhibitory Smads (Smad6 and Smad7). R-Smads are further subdivided into two subtypes: Smad2 and Smad3 for TGF-b and activin signaling pathways and Smad1, Smad5 and Smad8 for BMP signaling pathways. Among the three different classes of Smads, only R-Smads interact directly with activated type I receptors and become activated through phosphorylation of a conserved SSXS motif in their C-termini. R-Smads then form heteromeric complexes with Smad4, followed by nuclear translocation and regulation of gene transcription in collaboration with other transcription factors and transcriptional regulators. 5 During the processes of embryonic development and wound healing and reorganization in adult tissues, epithelial cells may lose their epithelial polarity and acquire mesenchymal phenotypes. In addition, the invasion process of tumor cells involves the loss of cell-cell interaction together with acquisition of migratory properties, and is often associated with epithelial-mesenchymal transdifferentiation (EMT) of cells. 6, 7 Formation of tight cell-cell adhesion is mainly dependent on the E-cadherin system both in embryonic and adult epithelial cells. Therefore, loss of E-cadherin-mediated interaction is an essential process for EMT that takes place during early normal embryonic development as well as during invasion of tumor cells into adjacent connective tissues. TGFb has been identified as an important molecule inducing EMT both in vivo and in vitro.
8 TGF-b2 is a candidate inducer of EMT in the atrioventricular tissues of the embryonic heart, 9 whereas TGF-b3 is responsible for EMT at palate fusion. 10 The mouse mammary epithelial cell line, NMuMG, has been shown to undergo EMT following TGF-b treatment. However, in other epithelial cells, including immortalized hepatocytes and MDCK cells, a synergistic effect between the H-Ras signal and the TGF-b signal appears to be required for the induction of a full EMT that occurs, at least in part, via the expression of a zinc-finger factor, Snail.
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The E2A proteins belong to the class I basic helix-loophelix (bHLH) family of transcriptional regulatory proteins, which function as dimers with the class II bHLH through an HLH domain. The E2A gene encodes two alternatively spliced products, E12 and E47, which differ in bHLH domains and hence their DNA-binding properties. 16 E2A proteins have been shown to be involved in the regulation of the expression of p21 in HeLa cells and MG63 cells, leading to growth arrest. 17 Recently, it has been shown that E2A proteins participate in the repression of E-cadherin expression by direct binding to the E-cadherin promoter region during the process of EMT in epithelial cells. 18 The transcriptional activity of E2A proteins can be negatively regulated by dimerization with another subclass of HLH factors, inhibitor of differentiation (Id) proteins, which contain functional HLH dimerization motifs but lack the basic DNA-binding region. 19, 20 More recently, Id expression has been demonstrated to be upregulated by BMP and downregulated by TGF-b through a transcriptional repressor, ATF-3, in various cell types. 21 In the present study, we investigated the regulatory mechanisms by which TGF-b was able to induce EMT in NMuMG cells. We show that the E2A gene products associate constitutively with, and are inactivated by Id proteins in NMuMG cells, leading to the expression of E-cadherin and maintenance of the epithelial phenotype. In contrast, downregulation of Id expression by TGF-b generates E2A that is free from Id proteins, thus allowing E2A to become active and induce EMT through repression of E-cadherin expression.
Results

EMT of NMuMG by TGF-b
TGF-b has been reported to induce EMT of NMuMG cells. 22 In untreated NMuMG cells, the characteristic epithelial phenotype with a strong cortical and diffuse cytoplasmic actin staining was observed by staining with tetramethylrhodamine B isocyanate (TRITC)-phalloidin, as shown previously ( Figure 1a and Piek et al. 22 ). Treatment with TGF-b dramatically induced actin fiber formation typical of transdifferentiation from the epithelial to mesenchymal phenotype, whereas BMP-4 failed to do so. In addition, staining of E-cadherin, a representative marker for differentiated epithe- We also analyzed the migratory property of NMuMG cells by a wound culture assay (Figure 1b ). Cells were scratched to produce wounds, and ligands were added to the culture medium. NMuMG cells treated with TGF-b showed highly migratory behavior at 20 h postincision, whereas BMP-4 was unable to significantly induce cell migration. These findings suggest that only TGF-b is able to elicit EMT in NMuMG cells.
Various epithelial and mesenchymal markers were quantitatively examined by immunoblotting whole-cell extracts from NMuMG cells (Figure 1c) . Treatment with TGF-b for 48 h resulted in the downregulation of E-cadherin expression with concomitant upregulation of representative markers for fibroblastic cells, that is, fibronectin and vimentin. In contrast, BMP-4 had no effect on the regulation of the expression of these proteins. We confirmed that in NMuMG cells, TGF-b induced phosphorylation of Smad2 and Smad1/5, whereas BMP-4 induced that of Smad1/5 ( Figure 1d ). These results suggest that TGF-b induces EMT of NMuMG cells possibly through the Smad2/3 pathway.
Regulation of expression of Id proteins by TGF-b
Since TGF-b is a potent cytokine that induces phenotypic transformation of epithelial cells, we investigated TGF-bregulated genes in HaCaT human keratinocyte cells by DNA microarray analysis (Akiyoshi et al. 23 and data not shown). Several representative genes were induced or suppressed by TGF-b in HaCaT cells; among those, we found that Id genes were slightly downregulated at 4 h after stimulation with TGFb, but were dramatically upregulated by BMP-4. In contrast, our microarray data from MG63 human osteosarcoma cells 5 in a 10 cm dish, and cultured overnight before stimulation with 100 pM TGF-b. After 24 h, cell extracts were prepared and processed to immunoprecipitation or were directly separated by SDS-PAGE. Endogenous E2A was immunoprecipitated with anti-E2A antibody pretreated with or without the E2A-blocking peptide, followed by immunoblotting with the same antibody (top panel). Endogenous Id1 co-immunoprecipitated with E2A was immunoblotted with the same anti-Id1 antibody (middle panel). Id1 from whole-cell lysates was also detected by immunoblotting with anti-Id1 antibody (bottom panel) determined by immunoblotting using whole-cell lysates (Figure 2c, bottom) . Taken together, these findings demonstrate that prolonged TGF-b treatment results in the downregulation of Id proteins and that E2A proteins are dissociated from Id proteins by TGF-b treatment in NMuMG cells.
Repression of E-cadherin promoter activity by TGF-b
To determine whether TGF-b regulates the promoter activity of E-cadherin, NMuMG cells were transfected with an Ecadherin promoter fused to a luciferase reporter gene, and luciferase activities were determined after 36 h stimulation of TGF-b. Similar to the data obtained from immunoblotting (Figure 1c) , the E-cadherin promoter was suppressed by TGF-b, but not by BMP-4 ( Figure 3a and data not shown). When constitutively active TGF-b type I receptor (TbR-I) was transfected, a reduction of E-cadherin promoter activity was also observed, although it was slightly less potent than the TGF-b ligand (data not shown). These findings indicate that TGF-b represses E-cadherin promoter activity in NMuMG cells.
Effects of E2A proteins on E-cadherin promoter activities
Next, we focused on the molecular function of E2A proteins in suppressing E-cadherin promoter activity. Transient transfection of E12 or E47 expression vectors into NMuMG cells showed that both E12 and E47 repressed E-cadherin promoter activity (Figure 3b ). Since both of these proteins interact with Id1, Id2 and Id3 (data not shown), we next cotransfected E2A constructs together with Id expression vectors to determine whether Id proteins can inactivate E2A function. As shown in Figure 3b , the reduction in luciferase activity induced by E12 or E47 was restored by Id1 or Id2. The expression levels of transfected Id1 and Id2 proteins were almost the same as the levels determined by immunoblotting (data not shown). Similar studies in MDCK cells showed that Id3 is able to fully overcome the E47-induced repression of Ecadherin promoter (Figure 3c ). These results indicate antagonistic effects of Id proteins on E2A-regulated transcriptional activities. 
Effect of stable expression of Id2 on EMT in NMuMG cells
Overexpression of E12 facilitates EMT in NMuMG cells
To further examine the role of Id proteins, the function of the Id proteins was suppressed by overexpression of E12 in NMuMG cells. After infection with pBabe vector or pBabeFlag-E12, cell extracts were prepared and expression of Flag-E12 was analyzed by immunoblotting. As shown in Figure 5a , NMuMG cells expressing E12 maintained low levels of Ecadherin expression in the presence and absence of TGF-b. Moreover, a high migratory behavior was observed in the E12-expressing cells compared to the pBabe vector-infected cells 
SB431542, a TbR-I inhibitor, blocked TGF-b-induced EMT and restored the expression of E-cadherin and Id2 proteins
Finally, we examined the effect of SB431542, a specific inhibitor of TbR-I, on TGF-b-induced EMT and expression of E-cadherin and Id proteins. As shown in Figure 6a and b, SB431542 almost completely blocked EMT induction and migration, and restored E-cadherin and Id2 expression regulated by TGF-b. These results suggest that TGF-b inhibitors might be used for the treatment of certain cancers through regulating EMT and cell migration.
Discussion
In the present study, we investigated the role of HLH transcriptional factors, Id and E2A, in the regulation of TGFb-induced EMT in NMuMG cells. We found that downregulation of Id proteins is, at least in part, required for TGFb-induced EMT. 21 reported that expression of Id1 by TGF-b is regulated by a transcriptional factor ATF-3 in epithelial cells. In contrast, Id2 is upregulated by c-myc oncoprotein in cancer cells and in cells treated with serum. 25, 26 More recently, it has been shown that Id2 expression is dependent on myc-max transcriptional complexes in HaCaT and NMuMG cells. 27 In contrast to Id1 and Id2, the molecular mechanism by which TGF-b regulates the expression of Id3 is still unclear. In B-lymphocyte cells, stimulation by TGF-b for 1 h increased the expression of Id3 mRNA, and Id2 was also upregulated by TGF-b. 28 Taken together, the mechanisms by which TGF-b regulates the expression of Id proteins may be different between each Id protein, and may be dependent on cell type.
The E2A proteins strongly repressed the promoter activity of the E-cadherin gene and its protein level in NMuMG cells (Figures 3b and 5a) , as well as in MDCK cells (Figure 3c , see also Perez-Moreno et al. 18 ). Overexpression of either Id1 or Id2 in NMuMG cells partially restored the expression of Ecadherin, while Id3 overexpression fully derepress E-cadherin promoter activity in MDCK cells. These findings suggest that Id proteins suppress the activity of E12/E47 proteins to inhibit E-cadherin promoter activity, and that molecules other than Id proteins may be required for this effect in a cell type-specific context. One of the candidate molecules may be Twist. 29 Twist was identified as an inhibitory molecule for E2A, and was shown to bind directly to E12 to inhibit the expression of the muscle creatine kinase gene. 30 Previous studies showed that Twist may be involved in the inhibition of differentiation of multiple cell lineages, especially mesenchymal cells, including muscle, cartilage and bone cells. 29 It would be interesting to examine whether Twist acts as a modulator of E2A action in NMuMG cells.
For repression of E-cadherin in the process of EMT, the zinc-finger factors, Snail 14, 31 and Slug, [32] [33] [34] and the Smadinteracting protein 1 (SIP1) 35 have been characterized previously. All of these proteins have been shown to bind directly to the promoter of the E-cadherin gene through specific E-boxes and to suppress its expression in various cell types. In fact, overexpression of these factors in NMuMG cells reduced E-cadherin promoter activity to levels similar to those induced by E2A proteins (data not shown). However, upregulation of these factors by TGF-b was not detected by RT-PCR (data not shown), and functional collaboration of these factors with Id proteins was not observed in NMuMG cells by monitoring for luciferase activity. Interestingly, we found that SIP1, but not Slug or Snail, interacted weakly with E2A in transfected COS-7 cells. Thus, an intriguing possibility is that E2A may cooperate with SIP1 in the regulation of E-cadherin expression, at least in cell-specific contexts.
Involvement of Smad pathways in the regulation of EMT is still controversial. RhoA has been shown to be a key player in exhibiting EMT by TGF-b, and its activity is independent of the inhibitory effect of Smad7. 36 However, we have observed that TGF-b-induced EMT in NMuMG cells was completely blocked by infection with Smad7 or Ski adenoviruses (data not shown) in agreement with other reports. 22, 37 In addition, downregulation of Id proteins by TGF-b was completely inhibited by these treatments. Taken together, these results support that TGF-binduced EMT in NMuMG cells is highly dependent on the Smad pathways. EMT is thought to be a phenomenon that is important for development in early embryonic stages and for the invasion and metastasis of cancer cells. Our results using a TGF-b receptor kinase inhibitor indicate that inhibition of TGF-b signaling may block the EMT and migration/invasion induced by TGF-b, suggesting that these inhibitors may be used for the treatment of certain cancers. In conclusion, we propose that E2A proteins regulate the steady-state level of E-cadherin in NMuMG cells through binding to Id proteins, thus maintaining the original epithelial cell morphology. After downregulation of Id proteins induced by TGF-b or after constitutive expression of E2A, the E2A proteins would be in molar excess of the inhibitory Id proteins, leading to transdifferentiation from epithelial to mesenchymal phenotypes in NMuMG cells.
Materials and Methods
Reagents, constructs and antibodies TGF-b3 and BMP-4 were purchased from R&D Systems (Minneapolis, MN, USA). The E-cadherin promoter (pGL2-pEDwt) containing the mouse promoter from À178 to þ 92 bp was fused to a luciferase reporter gene. 32 The cDNA constructs encoding E12 and E47 were from Dr. C Murre (University of California, CA, USA). The Id1 gene was obtained from Dr. H Weintraub (Fred Hutchinson Cancer Research Center, WA, USA), and the Id2 gene was as described previously. 38 Anti-phospho-Smad2 antibody and anti-phospho-Smad1/5 antibody were purchased from Cell-Signaling (Beverly, MA, USA). Anti-Id1, -Id2, -Id3 and -E2A antibodies and the blocking peptide against E2A were from Santa Cruz (Santa Cruz, CA, USA). Anti-E-cadherin antibody and anti-fibronectin antibody were purchased from BD Pharmingen (Transduction Laboratories, Lexington, KY, USA) and Calbiochem (San Diego, CA, USA), respectively. Antivimentin antibody was from Dako (Kyoto, Japan) and anti-a-tubulin from Sigma-Aldrich (St. Louis, MO, USA). SB-431542 was synthesized as described 39 and stored as a solution in DMSO. This solution was used after diluting with the medium for each assay.
Cell culture
Mouse NMuMG mammary epithelial cells (American Type Culture Collection) were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 4.5 g/l. glucose, 10% fetal bovine serum (FBS), 10 mg/ ml insulin, 100 U/ml penicillin and 100 mg/ml streptomycin. MDCK cells were grown in DMEM in the presence of 10% FBS, 10 mM glutamine and antibiotics. Cells were grown in a 5% CO 2 atmosphere at 371C.
RT-PCR analysis
Total RNA was isolated from NMuMG cells with Isogen (Nippon Gene, Tokyo, Japan) and first-strand cDNA was synthesized using the Superscript First-strand synthesis System (Invitrogen, Carlsbad, CA, USA) with random hexamer primers as described by the manufacturer's instructions. The expression of Id1, Id2, Id3 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was compared by semiquantitative RT-PCR analysis. A mouse GAPDH was used to normalize the amount of total cDNA in each sample. PCR conditions were 951C (1 min), 25 cycles of 951C (15 s 
Transfection, immunoprecipitation and immunoblotting
NMuMG cells and MDCK cells were transiently transfected using Fugene 6 (Roche Molecular Biochemicals) and Lipofectamine Plus (Gibco BRL), respectively. Immunoprecipitation and immunoblotting were performed using anti-Flag M2 antibody (Sigma-Aldrich) or other antibodies as described previously. 40 NMuMG cells or retrovirus-infected cells were grown to 90% confluency. After stimulation with 1.4 nM (50 ng/ml) BMP-4 or 100 pM TGF-b, cells were put on ice, rinsed with PBS (À) and lysed in RIPA buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% sodiumdeoxycholate and 0.1% SDS) for immunoblotting or in lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% NP-40, 1 mM EDTA, 1.5% aprotinin and 1 mM phenylmethylsulfonylfluoride) for immunoprecipitation. Cell lysates were quantitated by Bradford analysis for protein content and extracts containing equal amounts of total proteins were processed to SDS gel electrophoresis, followed by semidry transfer of the proteins to Pall Fluorotrans-W membrane (Pall corp.). Nonspecific binding of proteins to the membrane was blocked by incubation in TBS-T buffer (50 mM TrisHCl, pH 7.4, 150 mM NaCl and 0.1% Tween-20) containing 5% skim milk or 5% polyvinylpyrrolidone (Calbiochem). 41 The detection of immunoblotted proteins was performed by enhanced chemiluminescence.
Luciferase assay
NMuMG and MDCK cells were transiently transfected with appropriate combinations of reporter constructs (pGL2-pEDwt), expression plasmids and pcDNA3.0. The total amount of transfected DNAs was the same in each experiment. Luciferase activities were assayed by the luciferase assay system (Promega) and normalized to sea-pansy luciferase activity under the control of the thymidine kinase promoter.
Retrovirus vectors and generation of stable cell lines
pBabe-TRE was constructed by inserting a hygromycin resistance gene, followed by TRE and the minimal CMV promoter from pTRE (Clontech), between the modified gag gene and 3 0 -UTR of pBabe-puro. pBabe-tTA was constructed by inserting a puromycin resistance gene, followed by the CMV promoter and the tTA gene from pTET-OFF (Clontech), between the modified gag gene and 3 0 -UTR of pBabe-puro. 42 The cDNAs encoding Flag-tagged Id2 and E12 were subcloned into pBabe-TRE. To obtain stable cell lines, 293T cells were first cotransfected with pBabe-tTA and ecotropic-helper plasmids by Fugene 6 to produce culture supernatants containing virus. NMuMG cells were then infected with retrovirus by culturing for 2 days in the conditioned media with 8 mg/ml of polybrene before selection with 3 mg/ml of puromycin. Several puromycin-resistant clones were established and analyzed for inducible efficiencies after infection with pBabe-TRE-EGFP. The clones most efficiently expressing tTA, clones 9 and 15, were further infected with retrovirus in the conditioned media derived from 293T cells cotransfected with pBabe-TRE, pBabe-Flag-Id2 or pBabe-Flag-E12 and ecotropic-helper plasmids. After reselection with 1 mg/ml of hygromycin, the double resistant clones were maintained in DMEM supplemented with 4.5 g/l glucose, 10% FBS, 1 mg/ ml tetracycline (Tet), 1 mg/ml hygromycin and 3 mg/ml puromycin, before use in further experiments.
Transdifferentiation of NMuMG cells and analysis by fluorescence microscopy
NMuMG cells were seeded at a density of 0.75 Â 10 5 cells/well on glass coverslips in six-well plates. Approximately 6 h later, the medium was changed and cells were further cultured for 18 h. Cells were then stimulated with BMP-4 or TGF-b in the normal culture medium containing 10% FBS. The hygromycin and puromycin double resistant clones of NMuMG cells infected with pBabe-tTA and either pBabe-TRE or pBabeFlag-Id2 were maintained in DMEM supplemented with 4.5 g/l glucose, 10% FBS, 10 mg/ml insulin and antibiotics (1 mg/ml hygromycin and 3 mg/ ml puromycin) in the presence of 1 mg/ml Tet. Similar to normal NMuMG cells, the infected NMuMG cells were stimulated with TGF-b after they had been seeded in the presence or absence of Tet. After 24-36 h of stimulation, cells were treated to allow direct fluorescence of the actin cytoskeleton with 0.25 mM TRITC-conjugated phalloidin (Sigma-Aldrich, St. Louis, MO, USA) as described previously. 22 All specimens were mounted onto glass slides and observed by confocal laser scanning microscopy.
Migration assay
NMuMG cells and NMuMG cells infected with pBabe-TRE, pBabe-FlagId2 or pBabe-Flag-E12 were seeded at 1.5 Â 10 5 cells/well in six-well tissue culture plates. After cells reached 80% confluency, a wound was incised with a pipette tip in the central area of culture and 100 pM TGF-b or 1.4 nM BMP-4 was added. Photographs were taken under phase-contrast microscopy immediately after the incision, and after 18-24 h of ligand stimulation. When a wound was incised, an edge of the wound was marked with a thin line on the bottom of each well. After 18-24 h, the migration of wound edges (healing the wound area) from the line was measured at three random points. 43 
Invasion assays
Cell invasion assays were performed using a Cell Culture Insert (8 mm pore size; FALCON). Type IV collagen (BD Biosciences) was added to the Cell Culture Insert (5 mg/well) and dried. Cells pretreated with or without 40 pM TGF-b were split and reseeded in each well at a concentration of 4 Â 10 4 cells/well in the presence or absence of TGF-b. After 12 h, the cells that had not invaded were removed from the upper face of the filters using cotton swabs, and the cells that had invaded to lower surface of the filter were fixed in methanol and stained with Giemsa. Invasion was quantitated by visual counting after photographed. The mean of three random fields was obtained for each well. Each experiment was performed in triplicate. 44 Kato, A Hanyu and all the members of the Molecular Pathology Laboratory for critical comments. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan. KM is also supported by a VRIA grant from Boehringer Ingelheim. EC is supported by a fellowship from the Carlos III Institute.
